Indexing disease progression at study entry with individuals at-risk for Huntington disease
about
Magnetic resonance imaging striatal volumes: a biomarker for clinical trials in Huntington's diseaseHuntington's disease cerebrospinal fluid seeds aggregation of mutant huntingtin.Multivariate clustering of progression profiles reveals different depression patterns in prodromal Huntington disease.Prefrontal cortex white matter tracts in prodromal Huntington diseaseStatistical Approaches to Longitudinal Data Analysis in Neurodegenerative Diseases: Huntington's Disease as a Model.Disruption of response inhibition circuits in prodromal Huntington disease.Cognitive reserve and brain reserve in prodromal Huntington's disease.Clinical and Biomarker Changes in Premanifest Huntington Disease Show Trial Feasibility: A Decade of the PREDICT-HD StudyPrediction of manifest Huntington's disease with clinical and imaging measures: a prospective observational studyRegional atrophy associated with cognitive and motor function in prodromal Huntington disease.Neurochemical correlates of caudate atrophy in Huntington's disease.Longitudinal Psychiatric Symptoms in Prodromal Huntington's Disease: A Decade of Data.T1ρ imaging in premanifest Huntington disease reveals changes associated with disease progression.Longitudinal beta-binomial modeling using GEE for overdispersed binomial data.Executive functions in premanifest Huntington's disease.Dynamic Prediction of Motor Diagnosis in Huntington's Disease Using a Joint Modeling Approach.Functional connectivity of primary motor cortex is dependent on genetic burden in prodromal Huntington disease.Targeted Local Support Vector Machine for Age-Dependent Classification.Regionally selective atrophy of subcortical structures in prodromal HD as revealed by statistical shape analysis.Onset of Huntington's disease: can it be purely cognitive?Tracking motor impairments in the progression of Huntington's disease.Everyday cognition in prodromal Huntington diseaseWHODAS 2.0 in prodromal Huntington disease: measures of functioning in neuropsychiatric diseaseMovement sequencing in Huntington disease.Analysis of longitudinal censored semicontinuous data with application to the study of executive dysfunction: The Towers Task.Quantitative 7T phase imaging in premanifest Huntington disease.Ubiquitin: a potential cerebrospinal fluid progression marker in Huntington's disease.Novel Nut and Bolt Task Quantifies Motor Deficits in Premanifest and Manifest Huntington's DiseaseFUSED KERNEL-SPLINE SMOOTHING FOR REPEATEDLY MEASURED OUTCOMES IN A GENERALIZED PARTIALLY LINEAR MODEL WITH FUNCTIONAL SINGLE INDEX.Intra-individual Variability in Prodromal Huntington Disease and Its Relationship to Genetic BurdenPerformance of the 12-item WHODAS 2.0 in prodromal Huntington disease.Development of the Huntington disease work function scaleMeasuring executive dysfunction longitudinally and in relation to genetic burden, brain volumetrics, and depression in prodromal Huntington diseaseMultivariate prediction of motor diagnosis in Huntington's disease: 12 years of PREDICT-HDLinking white matter and deep gray matter alterations in premanifest Huntington diseasePlasma 24S-hydroxycholesterol correlation with markers of Huntington disease progression.Quantitative Susceptibility Mapping Suggests Altered Brain Iron in Premanifest Huntington Disease.Diffusion weighted imaging of prefrontal cortex in prodromal Huntington's disease.8OHdG as a marker for Huntington disease progressionModeling Variability in the Progression of Huntington's Disease A Novel Modeling Approach Applied to Structural Imaging Markers from TRACK-HD.
P2860
Q27004343-BE01D12B-19D9-4523-BB50-DD484B3E9456Q27318766-C1334527-D986-40ED-96FB-0CF615E476E9Q27333729-5C4CB50F-BDBA-4FC3-A25A-10E89B401C00Q27335055-BED0A362-0F28-4F5F-A55D-6008C970DC91Q30235601-4EC96CD9-A4FA-40A1-83E8-4FCEE4B1E8ECQ30403689-C6B4025F-094B-4121-9FFA-162698DEE3AEQ30541757-3881F403-58D7-42E0-84ED-93768DCECAB9Q30577157-E8A64F5E-ECEC-44B9-B48B-FC5D85B19BA1Q30631995-42ACB343-8045-4BB5-931A-6F64E651857DQ30644807-41937E28-D1DF-43B2-A380-B51D4530D7E7Q30737232-859FF72E-75FB-4926-BAD2-3FDBA7652596Q30855262-A3D9F3E3-9E8D-4F23-9F7C-3C61420ECEE9Q30919084-E2A5198A-8E44-4C19-B50C-0F55058491ABQ31146852-1A324807-2ABF-4760-9A05-858733A513DFQ33643202-E05C6388-8F8F-41E9-9734-52C71318D0C0Q33894395-73FF72C5-18D3-4636-A2D3-2587C5BC1146Q34096680-BB137808-5736-4E25-93C8-26E427E37ED3Q34281421-1F51ED68-57BA-4E93-A7FE-43B3B1B72738Q34320446-1028F810-325C-44C7-BC3B-E9F8810526E5Q34322005-421CF72C-A705-4C22-983D-E948E3DC0BC6Q34449476-FDF9E5C7-A6DF-44AA-B2E5-5992090AFBD2Q34861585-41A8797F-1E5F-49BB-9BA1-3DFAB1413704Q35150473-475413E3-C83F-4E9E-A749-9C0FCC9490A5Q35312436-45EB63C2-6756-403F-A3DD-CFB15F772CA9Q35458199-548483E0-A653-45F4-8CDB-105555982E80Q35586792-9200C1B4-6429-4228-AEB0-3B94748FBE46Q35663352-B2F4E48E-C845-460D-A7AB-84E78007EF3EQ35793031-9D6F05EA-C88A-4C64-B39B-736A4D452F13Q35955107-5909B574-A9CE-4133-8D3F-E92A140D0556Q35997096-18B0AD51-81F8-45CD-933F-E6D1B65BDB76Q36184559-9CD7F232-80FD-407E-8850-40691D86E370Q36303727-EEC2F0A1-B92D-4ADA-9E40-7C804C03D3D1Q36603018-FF7610AF-A918-4A7D-826D-7842224DD2FCQ36696620-D79B35CD-1CED-4D04-8585-FB00AA317DCAQ36787332-A8404E9F-B9F3-4618-8090-7E1A211E64F4Q36900689-F59DBC4B-A1E9-44C5-9F95-C9A592CACEE4Q36902073-18B75A1D-5388-4134-8982-6C6D194BE547Q37179508-AFD887C3-0C44-479C-B4C0-443F7A813101Q37199696-B5F15836-1FDD-4DAF-ABDF-C429DAA50997Q37208514-EAE77030-0F47-44AA-B721-979134C7B2EB
P2860
Indexing disease progression at study entry with individuals at-risk for Huntington disease
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Indexing disease progression a ...... at-risk for Huntington disease
@ast
Indexing disease progression a ...... at-risk for Huntington disease
@en
type
label
Indexing disease progression a ...... at-risk for Huntington disease
@ast
Indexing disease progression a ...... at-risk for Huntington disease
@en
prefLabel
Indexing disease progression a ...... at-risk for Huntington disease
@ast
Indexing disease progression a ...... at-risk for Huntington disease
@en
P2093
P2860
P356
P1476
Indexing disease progression a ...... at-risk for Huntington disease
@en
P2093
James A Mills
John H Warner
PREDICT-HD Investigators and Coordinators of the Huntington Study Group
Wenjing Lu
Ying Zhang
P2860
P304
P356
10.1002/AJMG.B.31232
P577
2011-08-19T00:00:00Z